These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33031122)

  • 21. Emergency medicine services providers' attitudes toward naloxone distribution and training programs.
    Montoy JCC; Mercer MP; Silverman EC; Raven MC; LeSaint KT
    Am J Emerg Med; 2022 Jan; 51():76-78. PubMed ID: 34688204
    [No Abstract]   [Full Text] [Related]  

  • 22. Emergency department naloxone rescue kit dispensing and patient follow-up.
    Kaucher KA; Acquisto NM; Broderick KB
    Am J Emerg Med; 2018 Aug; 36(8):1503-1504. PubMed ID: 29237542
    [No Abstract]   [Full Text] [Related]  

  • 23. Implementation of a naloxone dispensing program in a grocery store-based community pharmacy.
    Wilkerson DM; Groves BK; Mehta BH
    Am J Health Syst Pharm; 2020 Mar; 77(7):511-514. PubMed ID: 32086505
    [No Abstract]   [Full Text] [Related]  

  • 24. Identifying Patients for Overdose Prevention With ICD-9 Classification in the Emergency Department, Massachusetts, 2013-2014.
    Ellison J; Walley AY; Feldman JA; Bernstein E; Mitchell PM; Koppelman EA; Drainoni ML
    Public Health Rep; 2016 Sep; 131(5):671-675. PubMed ID: 28123207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of lower-dose versus higher-dose intravenous naloxone on time to recurrence of opioid toxicity in the emergency department.
    Wong F; Edwards CJ; Jarrell DH; Patanwala AE
    Clin Toxicol (Phila); 2019 Jan; 57(1):19-24. PubMed ID: 30032680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing peer recovery services for overdose prevention in Rhode Island: An examination of two outreach-based approaches.
    Waye KM; Goyer J; Dettor D; Mahoney L; Samuels EA; Yedinak JL; Marshall BDL
    Addict Behav; 2019 Feb; 89():85-91. PubMed ID: 30278306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Take -home naloxone rescue kits following heroin overdose in the emergency department to prevent opioid overdose related repeat emergency department visits, hospitalization and death- a pilot study.
    Papp J; Vallabhaneni M; Morales A; Schrock JW
    BMC Health Serv Res; 2019 Dec; 19(1):957. PubMed ID: 31829228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Documenting need for naloxone distribution in the Los Angeles County jail system.
    Davidson PJ; Wagner KD; Tokar PL; Scholar S
    Addict Behav; 2019 May; 92():20-23. PubMed ID: 30576883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radical red tape reduction by government supported nasal naloxone: the Norwegian pilot project is innovative, safe and an important contribution to further development and dissemination of take-home naloxone.
    Lobmaier PP; Clausen T
    Addiction; 2016 Apr; 111(4):586-7. PubMed ID: 26995169
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug Toxicity Deaths after Release from Incarceration in Ontario, 2006-2013: Review of Coroner's Cases.
    Groot E; Kouyoumdjian FG; Kiefer L; Madadi P; Gross J; Prevost B; Jhirad R; Huyer D; Snowdon V; Persaud N
    PLoS One; 2016; 11(7):e0157512. PubMed ID: 27384044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.
    Herring AA; Schultz CW; Yang E; Greenwald MK
    Am J Emerg Med; 2019 Dec; 37(12):2259-2262. PubMed ID: 31239086
    [No Abstract]   [Full Text] [Related]  

  • 32. [Distribution of naloxone to prevent death from heroin overdose. Study of opioid dependent patients' attitudes to be part of the antidote program].
    Håkansson A; Vedin A; Wallin C; Kral AH
    Lakartidningen; 2013 Jul 17-Aug 6; 110(29-31):1340-2. PubMed ID: 23980443
    [No Abstract]   [Full Text] [Related]  

  • 33. The pharmacist's role in overdose: Using mapping technologies to analyze naloxone and pharmacy distribution.
    Burrell A; Ethun L; Fawcett JA; Rickard-Aasen S; Williams K; Kearney SM; Pringle JL
    J Am Pharm Assoc (2003); 2017; 57(2S):S73-S77.e1. PubMed ID: 28109629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. China White epidemic: an eastern United States emergency department experience.
    Martin M; Hecker J; Clark R; Frye J; Jehle D; Lucid EJ; Harchelroad F
    Ann Emerg Med; 1991 Feb; 20(2):158-64. PubMed ID: 1996799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine-Naloxone Tablets.
    Hampp C; Lovegrove MC; Budnitz DS; Mathew J; Ho A; McAninch J
    Drug Saf; 2020 Feb; 43(2):189-191. PubMed ID: 31745829
    [No Abstract]   [Full Text] [Related]  

  • 36. Scotland's National Naloxone Programme.
    Bird SM; McAuley A
    Lancet; 2019 Jan; 393(10169):316-318. PubMed ID: 30696566
    [No Abstract]   [Full Text] [Related]  

  • 37. Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.
    Heavey SC; Delmerico AM; Burstein G; Moore C; Wieczorek WF; Collins RL; Chang YP; Homish GG
    J Community Health; 2018 Apr; 43(2):304-311. PubMed ID: 28852906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overdose prevention for prisoners in New York: a novel program and collaboration.
    Zucker H; Annucci AJ; Stancliff S; Catania H
    Harm Reduct J; 2015 Nov; 12():51. PubMed ID: 26541987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges with take-home naloxone in reducing heroin mortality: a review of fatal heroin overdose cases in Victoria, Australia.
    Stam NC; Gerostamoulos D; Smith K; Pilgrim JL; Drummer OH
    Clin Toxicol (Phila); 2019 May; 57(5):325-330. PubMed ID: 30451007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.